GlassScriptPhysician profile
Keeli A Howe
NPI 1639371354
$1,213.64
in general payments reported to CMS, 2019-2025
17 companies · $275 in 2025
The $275 reported for 2025 was more than what 83% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $118 · 2023: $331 · 2024: $230 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $291.93 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $170.29 | 2022-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $125.62 | 2021-2025 | Bexsero, Rotarix, Pediarix |
| Sanofi Pasteur INC. | $82.99 | 2021-2025 | |
| Tris Pharma INC | $81.27 | 2021-2023 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $79.64 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $64.74 | 2021-2025 | Qelbree |
| Adlon Therapeutics L.P. | $63.54 | 2021 | |
| Collegium Pharmaceutical, INC. | $56.30 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $49.02 | 2023-2024 | Flumist Quadrivalent |
| Regeneron Healthcare Solutions, INC. | $38.35 | 2023 | Dupixent |
| Pfizer INC. | $26.22 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $21.79 | 2021 | |
| Abbvie INC. | $16.86 | 2021 | |
| Kaleo, INC. | $16.44 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.98 | 2025 | |
| Ucb, INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keeli Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.